Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

rellife.com

About Reliance Life Sciences

Reliance Life Sciences is a research-driven organization developing business opportunities in bio-therapeutics (plasma proteins, biosimilars and novel proteins), pharmaceuticals (later-generation, oncology generics), clinical research services, regenerative medicine (stem cells therapies) and molecular medicine. It is located in Navi Mumbai, Maharashtra.

Reliance Life Sciences Headquarters Location

Thane Belapur Road, Rabale R-282, TTC Area of MIDC

Navi Mumbai, 400701,

India

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Reliance Life Sciences News

India’s Reliance secures DCGI nod to carry out Phase I Covid-19 vaccine trial

Sep 6, 2021

X The Drugs Controller General of India (DCGI) has given approval to Reliance Life Sciences to conduct a Phase I clinical trial of its Covid-19 vaccine with certain conditions. The trial will also analyse the maximum tolerated dose of the two-dose vaccine. Credit: torstensimon from Pixabay Subscribe to our email newsletter This trial will evaluate the safety, tolerability and immunogenicity of Reliance’s vaccine against Covid-19 infection in healthy subjects. The trial will also analyse the maximum tolerated dose of the two-dose vaccine, reported PTI. The Phase I trial usually lasts for 58 days. The Subject Expert Committee of the Central Drugs Standard Control Organisation (CDSCO) had recommended commencement of Phase I trials of the SARS-CoV-2 recombinant Covid vaccine candidate. The DCGI conditions requires the firm to submit the updated clinical trial protocol for immunogenicity to be analysed on day 42, instead of 14. Reliance will conduct the trial at eight centres in Maharashtra state. Last year, the development of the firm’s recombinant protein-based vaccine reportedly commenced. So far, the Indian regulatory authority granted emergency use authorisation to six Covid-19 vaccines. These vaccines comprise Serum Institute of India’s Covishield, Bharat Biotech’s Covaxin, Zydus Cadila’s ZyCoV-D, Russia’s Sputnik V, Moderna’s vaccine and Johnson & Johnson’s vaccine. Related

Reliance Life Sciences Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Reliance Life Sciences Rank

  • Where is Reliance Life Sciences's headquarters?

    Reliance Life Sciences's headquarters is located at Thane Belapur Road, Rabale, Navi Mumbai.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.